Decreased effectiveness of 0.01% atropine treatment for myopia control during prolonged COVID-19 lockdowns
Nir Erdinest, N. London, Nadav Levinger, Itay Lavy, Eran Pras, Yair Morad
Topics & Concepts
Coronavirus disease 2019 (COVID-19)PandemicAtropineMedicine2019-20 coronavirus outbreakOphthalmologyDemographyPediatricsOutbreakInternal medicineVirologySociologyDiseaseInfectious disease (medical specialty)Ophthalmology and Visual Impairment StudiesCorneal surgery and disorders